News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,509 Results
Type
Article (3229)
Company Profile (3)
Press Release (21276)
Multimedia
Podcasts (18)
Webinars (1)
Section
Business (8043)
Career Advice (75)
Deals (1063)
Drug Delivery (10)
Drug Development (4090)
Employer Resources (7)
FDA (699)
Job Trends (697)
News (13371)
Policy (1067)
Tag
Academia (73)
Accelerated approval (1)
Adcomms (1)
Allergies (7)
Alliances (2077)
Alzheimer's disease (110)
Antibody-drug conjugate (ADC) (21)
Approvals (697)
Artificial intelligence (25)
Autoimmune disease (4)
Automation (2)
Bankruptcy (6)
Best Places to Work (497)
Biosimilars (12)
Biotechnology (3)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (44)
Cancer (248)
Cardiovascular disease (13)
Career advice (69)
Career pathing (2)
CAR-T (5)
CDC (2)
Cell therapy (29)
Cervical cancer (7)
Clinical research (3284)
Collaboration (92)
Company closure (1)
Compensation (4)
Complete response letters (6)
COVID-19 (215)
C-suite (50)
Cystic fibrosis (2)
Data (176)
Depression (4)
Diabetes (20)
Diagnostics (248)
Diversity, equity & inclusion (1)
Drug discovery (10)
Drug pricing (7)
Drug shortages (4)
Duchenne muscular dystrophy (24)
Earnings (2102)
Editorial (6)
Employer branding (4)
Employer resources (6)
Events (2200)
Executive appointments (56)
FDA (783)
Funding (46)
Gene editing (3)
Gene therapy (36)
GLP-1 (74)
Government (197)
Guidances (7)
Healthcare (510)
HIV (2)
Huntington's disease (11)
IgA nephropathy (1)
Immunology and inflammation (24)
Immuno-oncology (4)
Indications (2)
Infectious disease (221)
Inflammatory bowel disease (14)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (3)
Interviews (7)
IPO (333)
IRA (1)
Job creations (218)
Job search strategy (60)
Labor market (4)
Layoffs (58)
Leadership (4)
Legal (209)
Liver cancer (14)
Longevity (1)
Lung cancer (33)
Lymphoma (36)
Management (1)
Manufacturing (56)
MASH (9)
Medical device (170)
Medtech (170)
Mergers & acquisitions (758)
Metabolic disorders (83)
Multiple sclerosis (24)
NASH (1)
Neurodegenerative disease (27)
Neuropsychiatric disorders (5)
Neuroscience (182)
NextGen: Class of 2025 (197)
Non-profit (151)
Now hiring (3)
Obesity (55)
Opinion (25)
Ovarian cancer (5)
Pain (2)
Pancreatic cancer (4)
Parkinson's disease (13)
Partnered (1)
Patents (10)
Patient recruitment (6)
Peanut (3)
People (3530)
Phase I (1004)
Phase II (1351)
Phase III (1365)
Pipeline (134)
Policy (17)
Postmarket research (195)
Preclinical (311)
Press Release (1)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (10)
Rare diseases (25)
Real estate (182)
Recruiting (4)
Regulatory (840)
Reports (6)
Research institute (93)
Resumes & cover letters (11)
Rett syndrome (1)
RNA editing (1)
RSV (2)
Schizophrenia (5)
Series A (12)
Series B (9)
Sickle cell disease (1)
Special edition (5)
Spinal muscular atrophy (57)
Startups (184)
Stomach cancer (5)
Supply chain (7)
Tariffs (26)
The Weekly (18)
Vaccines (41)
Venture capital (8)
Weight loss (39)
Women's health (1)
Date
Today (3)
Last 7 days (21)
Last 30 days (80)
Last 365 days (948)
2025 (895)
2024 (1191)
2023 (1243)
2022 (2615)
2021 (2279)
2020 (2018)
2019 (1367)
2018 (1149)
2017 (1058)
2016 (995)
2015 (1313)
2014 (912)
2013 (756)
2012 (908)
2011 (1026)
2010 (1003)
Location
Africa (55)
Alabama (2)
Arizona (13)
Asia (1186)
Australia (178)
California (305)
Canada (45)
China (33)
Connecticut (9)
Delaware (2)
Europe (4554)
Florida (10)
Georgia (1)
Illinois (25)
Indiana (14)
Japan (4)
Kentucky (2)
Louisiana (1)
Maryland (15)
Massachusetts (217)
Michigan (7)
Minnesota (18)
Nevada (2)
New Jersey (41)
New York (102)
North Carolina (19)
Northern California (169)
Ohio (2)
Pennsylvania (20)
Rhode Island (2)
South America (50)
Southern California (92)
Tennessee (1)
Texas (20)
United States (908)
Utah (11)
Vermont (1)
Virginia (6)
Washington D.C. (2)
Washington State (82)
Wisconsin (1)
24,509 Results for "roche".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Autoimmune disease
Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus
The anti-CD20 antibody, developed by Roche’s Genentech along with Biogen and already approved for multiple oncology indications, is branching into autoimmune disease. Its B cell–targeting mechanism of action gives it activity in improving kidney conditions in patients with lupus nephritis.
October 20, 2025
·
2 min read
·
Dan Samorodnitsky
Alzheimer’s disease
I Remember Aduhelm. The Return of Roche in Alzheimer’s Is a Turning Point
After covering the Alzheimer’s space through every high and low,
BioSpace
’s Annalee Armstrong welcomes back Roche for the 2026 Alzheimer’s Renaissance.
December 2, 2025
·
2 min read
·
Annalee Armstrong
Neuroscience
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold
Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central nervous system.
November 3, 2025
·
1 min read
·
Annalee Armstrong
Drug pricing
In Affordability Push, EMD Serono Joins TrumpRx While Roche Launches DTC Program
EMD Serono will offer its fertility treatments on TrumpRx at a steep discount, and Roche’s direct-to-consumer offering will cover its flu pill Xofluza.
October 17, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
Regulatory documents show how 89bio’s board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments.
October 2, 2025
·
3 min read
·
Annalee Armstrong
Antibody-drug conjugate (ADC)
Roche Inks Another China ADC Pact With $1.5B Hansoh Bet
Roche will gain worldwide rights outside of the Greater China region to Hansoh’s HS-20110, an antibody-drug conjugate in early-stage development for colorectal cancer.
October 17, 2025
·
2 min read
·
Tristan Manalac
Inflammatory bowel disease
Roche Makes Preclinical IBD Play in $420M+ OMass Pact
The OMass partnership will boost Roche’s strategy in inflammatory bowel diseases, currently led by afimkibart, an anti-TL1A therapy the pharma obtained from its $7.1 billion acquisition of Telavant in 2023.
September 2, 2025
·
2 min read
·
Tristan Manalac
Earnings
‘We’re Not Done’: Roche Plans To Sustain Dealmaking Pace After 89bio
Roche has already signed several high-ticket deals this year, including the $3.5 billion acquisition of 89bio and Genentech’s $2.1 billion molecular glue pact with Orionis Biosciences.
October 23, 2025
·
2 min read
·
Tristan Manalac
Complete response letters
Lack of US Data Stymie Roche’s Earlier-Stage Lymphoma Push for Columvi
Roche and Genentech were unable to sufficiently demonstrate the benefit of using Columvi in an earlier treatment setting for DLBCL in a U.S. population, according to the FDA.
July 21, 2025
·
2 min read
·
Tristan Manalac
Immunology and inflammation
Roche Flunks Phase III Trial in COPD, Falling Further Behind Dupixent
The path to market for Roche’s astegolimab became more uncertain after the investigational antibody failed to significantly lower disease exacerbation rates versus placebo in patients with chronic obstructive pulmonary disease.
July 21, 2025
·
2 min read
·
Tristan Manalac
1 of 2,451
Next
